Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?

Dermatol Ther. 2022 Sep;35(9):e15697. doi: 10.1111/dth.15697. Epub 2022 Jul 19.

Authors

Luca Mastorino¹, Gabriele Roccuzzo¹, Paolo Dapavo¹, Niccolò Siliquini¹, Gianluca Avallone¹, Marco Rubatto¹, Pietro Quaglino¹, Simone Ribero¹

Affiliation

¹ Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.

No abstract available

Publication types

Letter

MeSH terms

Humans
Interleukin-17*
Interleukin-23*

Substances

Interleukin-17
Interleukin-23